Molecular Inflammation Board for personalized care of chronic inflammatory diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational program that documents all patients referred to the Molecular Inflammation Board at the Center for Personalized Medicine. It captures clinical outcomes, peripheral immune monitoring, imaging parameters, patient-reported outcomes, and records whether clinicians follow the board's recommendations. The effort is coordinated at University Hospital Tübingen with collaboration from University Hospitals Freiburg, Heidelberg, and Ulm. No experimental treatment is assigned by the program; biologic therapies used in routine care are recorded and analyzed.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Chronic inflammatory disorder (PsO, PsA, SpA, IBD)
* Given informed consent
* 18 years of age

Exclusion Criteria:

* No capacity to consent

Where it's running

• University Hospital of Tübingen - Center for Personalized Medicine
  Tübingen, Germany Recruiting

Study contacts

• Study coordinator: Nisar P Malek, Prof. Dr.
• Email: zpm-meb@med.uni-tuebingen.de
• Phone: +4970712982722

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Familial IBD Early Risk

  This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.

  Recruiting Seattle Children's Hospital · Seattle, Washington · NCT07791862

• Modafinil for Debilitating Fatigue in Quiescent IBD

  A study will test whether modafinil can help adults with Crohn’s disease or ulcerative colitis who feel very fatigued even when their IBD is quiet.

  Recruiting at 2 sites Phase 2/3 Radboud University Medical Center · Arnhem, Gelderland and 1 other locations · NCT07582458

• Traditional Chinese Medicine diagnostics and tongue-coating metabolomics to characterize inflammatory bowel disease

  This study will test whether TCM diagnostic tools and tongue-coating metabolomics can identify characteristic signs in adults with Crohn's disease or ulcerative colitis compared with people without IBD.

  Recruiting China Medical University Hospital · Taichung, North · NCT07314151

• Assessing the effects of IL-17 inhibitors on hidden inflammation in psoriasis patients

  This study is testing if IL-17 inhibitors can help reduce hidden inflammation in adults with moderate to severe psoriasis who aren't getting enough relief from their current treatments.

  Recruiting at 2 sites The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu and 1 other locations · NCT06987292

• Measuring Calprotectin Levels in Stool for Diagnosing Inflammatory Bowel Disease

  This study is testing a new stool test to see if it can help doctors diagnose Inflammatory Bowel Diseases like Crohn's and Ulcerative Colitis more accurately.

  Recruiting at 2 sites American Laboratory Products Company · Miami, Florida and 2 other locations · NCT06810518

• Retinal Vessel Density and Foveal Avascular Zone Size in Psoriatic Arthritis

  This study tests whether retinal blood vessel density and the size of the foveal avascular zone differ between people with psoriatic arthritis, people with psoriasis, and healthy individuals using non-invasive eye imaging.

  Recruiting Bursa Yuksek Ihtisas Training and Research Hospital · Bursa, Yıldırım · NCT07858591

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.